IGF1 and fatty liver disease: Similarly, other studies have shown increased hepatic steatosis and fibrosis in acromegaly [15], with 83.8% of newly diagnosed patients presenting an elevated hepatic steatosis index, independent of GH, IGF-1, or metabolic markers [1].